3 Stocks Under $10 Making Big Moves

 

DELAFIELD, Wis. (Stockpickr) -- As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

InspireMD

InspireMD (NSPR), a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. This stock is trading up 13.4% to 28 cents per share in Tuesday's trading session.

Tuesday's Range: $0.26-$0.28
52-Week Range: $0.19-$3.25
Tuesday's Volume: 377,000
Three-Month Average Volume: 995,602

From a technical perspective, InspireMD is ripping higher here right off its 50-day moving average of 26 cents per share with lighter-than-average volume. This stock has been uptrending over the last month and change, with shares moving higher from its low of 19 cents per share to its recent high of 32 cents per share. During that uptrend, shares of InspireMD have been making mostly higher lows and higher highs, which is bullish technical price action. This spike to the upside on Tuesday is now starting to push shares of InspireMD within range of triggering a major breakout trade. That trade will hit if this stock manages to take out some key near-term overhead resistance levels at 30 cents to 32 cents per share with high volume.

Traders should now look for long-biased trades in InspireMD as long as it's trending above its 50-day moving average of 26 cents per share or its 20-day moving average of 25 cents per share and then once it sustains a move or close above those breakout levels with volume that registers near or above 995,602 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at 35 to 38 cents per share. Any high-volume move above 38 cents per share will then give this stock a chance to re-fill some of its previous gap-down-day zone from March that started at 60 cents per share.

Amarin

Amarin (AMRN), a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the U.S. This stock is trading up 1.2% to $2.45 in Tuesday's trading session.

Tuesday's Range: $2.39-$2.47
52-Week Range: $0.78-$3.33
Tuesday's Volume: 909,000
Three-Month Average Volume: 4.20 million

From a technical perspective, Amarin is trending modestly higher here right above some near-term support at $2.29 with lighter-than-average volume. This stock has been consolidating and trending sideways over the last few weeks, with shares moving between $2.29 on the downside and $2.52 on the upside. Shares of Amarin are now starting to spike higher off that $2.29 low and it's beginning to move within range of triggering a major breakout trade above the upper-end of its recent sideways trending chart pattern. That trade will trigger if this stock manages to take out some key near-term overhead resistance at $2.49 to $2.52 with high volume.

Traders should now look for long-biased trades in Amarin as long as it's trending above some near-term support at $2.29 or above its 50-day at $2.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 4.20 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.80 to around $3. Any high-volume move above $3 will then give this stock a chance to tag its 52-week high of $3.33.

Mela Sciences

Mela Sciences (MELA), a medical device company, designs and develops software-driven technology for the early detection of skin cancer to dermatologists in the U.S. This stock is trading up 3.1% to $1.62 in Tuesday's trading session.

Tuesday's Range: $1.58-$1.62
52-Week Range: $1.11-$4.05
Tuesday's Volume: 27,000
Three-Month Average Volume: 219,328

From a technical perspective, Mela Sciences is spiking notably higher here right above some near-term support at $1.50 with lighter-than-average volume. This stock recently formed a double bottom chart pattern at $1.40 to $1.43 a share. Following that bottom, shares of MELA Sciences have now started to spike a bit higher and it's beginning to move within range of triggering a major breakout trade. That trade will trigger if this stock manages to clear some key near-term overhead resistance levels at its 50-day moving average of $1.62 to $1.64 and then once it takes out its 200-day moving average of $1.70 to $1.80 with high volume.

Traders should now look for long-biased trades in Mela Sciences as long as it's trending above some near-term support levels at $1.50 or above those double bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 219,328 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to $3 a share.

This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

If you liked this article you might like

Biotech Premarket Movers: Cempra, Novavax, Ionis

Biotech Premarket Movers: Cempra, Novavax, Ionis

Amarin (AMRN) Stock Drops After Pricing Public Offering

Amarin (AMRN) Stock Drops After Pricing Public Offering

Tetraphase Executive Profits Hours Before Stock Plummets

Tetraphase Executive Profits Hours Before Stock Plummets

5 Stocks Ready for Breakouts -- Must-See Charts

5 Stocks Ready for Breakouts -- Must-See Charts